Federal Register of Legislation - Australian Government

Primary content

PB 9 of 2013 Determinations/Health as made
This instrument amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to provide for changes to the conditions subject to which payments will be made by the Commonwealth in respect of the supply of pharmaceutical benefits by approved pharmacists and approved medical practitioners.
Administered by: Health
Made 07 Feb 2013
Registered 14 Feb 2013
Tabled HR 12 Mar 2013
Tabled Senate 25 Feb 2013
Date of repeal 02 Mar 2013
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

PB 9 of 2013

 

Amendment determination under paragraph 98C(1)(b) of the National Health Act 19531

_____________________________________________________________________

 

 

I, KIM BESSELL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 07 February 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KIM BESSELL

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health and Ageing

 

 

 

1              Name of Instrument

(1)                This Instrument is the Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953.

(2)                This Instrument may also be cited as PB 9 of 2013.

2              Commencement                                                        

                This instrument commences on 1 March 2013.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).



Schedule 1            Amendments

 

[1]        Schedule 4, after entry for Macrogol 3350 in the form Sachets containing powder for oral solution 13.125 g with electrolytes, 30

insert in the column headed “Form (strength, type, size, etc.):

 

Sachets containing powder for oral solution 17 g, 30

[2]        Schedule 4, after entry for Testosterone in the form Transdermal patches
24.3 mg, 30

insert in the column headed “Form (strength, type, size, etc.):

 

Transdermal solution (pump pack) 30 mg per 1.5 mL dose, 60 doses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 

See http://www.comlaw.gov.au.